grazoprevir   Click here for help

GtoPdb Ligand ID: 11573

Synonyms: analog 15 [PMID: 24900473] | MK-5172 | MK5172 | Zepatier® [elbasvir (NS5A inhibitor) + grazoprevir]
Approved drug PDB Ligand
grazoprevir is an approved drug (FDA (2016), UK (2021))
Compound class: Synthetic organic
Comment: Grazoprevir (MK-5172) is an HCV NS3/4A protease inhibitor class antiviral drug [2]. In vitro evidence of activity against SARS-CoV-2 helicase [1] and papain-like protease (PLpro) [3].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 13
Hydrogen bond donors 3
Rotatable bonds 10
Topological polar surface area 203.6
Molecular weight 766.34
XLogP 4.05
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@@H](NC(=O)O[C@@H]1C[C@H]1CCCCCc1c(O2)nc2cc(OC)ccc2n1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1
Isomeric SMILES C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@@H](NC(=O)O[C@@H]1C[C@H]1CCCCCc1c(O2)nc2cc(OC)ccc2n1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1
InChI InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1
InChI Key OBMNJSNZOWALQB-NCQNOWPTSA-N
References
1. Abidi SH, Almansour NM, Amerzhanov D, Allemailem KS, Rafaqat W, Ibrahim MAA, la Fleur P, Lukac M, Ali S. (2021)
Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase.
Sci Rep, 11 (1): 10290. DOI: 10.1038/s41598-021-89724-0 [PMID:33986405]
2. Harper S, McCauley JA, Rudd MT, Ferrara M, DiFilippo M, Crescenzi B, Koch U, Petrocchi A, Holloway MK, Butcher JW et al.. (2012)
Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor.
ACS Med Chem Lett, 3 (4): 332-6. [PMID:24900473]
3. Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N. (2021)
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.
Bioorg Chem, 106: 104490. [PMID:33261845]